Prescribing of methylphenidate to children and adolescents in South Africa: A pharmacoepidemiological investigation

South African Family Practice

Volumn 51, Issue 5, 2009, Pages 413-417

  Truter, Ilse ^a  

^a NELSON MANDELA METROPOLITAN UNIVERSITY   (South Africa)

Author keywords

Adolescents; Attention deficit hyperactivity disorder (ADHD); Children; Drug utilisation; Methylphenidate; Pharmacoepidemiology

Indexed keywords

LONG ACTING DRUG; METHYLPHENIDATE;

ADOLESCENT; ADOLESCENT HEALTH; ADULT; AGE; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CHILD HEALTH; CONTROLLED STUDY; DRUG COST; GEOGRAPHIC DISTRIBUTION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MEDICAL ASSISTANT; MEDICAL RECORD REVIEW; PHARMACOEPIDEMIOLOGY; PRESCHOOL CHILD; PRESCRIPTION; SCHOOL CHILD; SOUTH AFRICA;

EID: 70449642775     PISSN: 20786190     EISSN: 20786204     Source Type: Journal    
DOI: 10.1080/20786204.2009.10873894     Document Type: Article

References (18)

1. Robison LM, Sclar DA, Skaer TL, Galin RS. National trends in the prevalence of attention-deficit/ hyperactivity disorder and the prescribing of methylphenidate among school-age children: 1990-1995. Clin Pediatr 1999;38(4):209-217
2. Schachter HM, Pham B, King J, Langford S, Moher D. How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A metaanalysis. CMAJ 27 November 2001;165(11):1475-1488
3. Rowland AS, Lesesne CA, Abramowitz AJ. The epidemiology of attention-deficit/hyperactivity disorder (ADHD): A public health view. Ment Retard Dev Disab Res Rev 2002;8(3):162-170 [Abstract.]
4. Wick JY. Use of psychoactive medications in children and adolescents. Am Pharm 1993;NS33(1):51-58
5. Vinker S, Vinker R, Elhayany. Prevalence of methylphenidate use among Israeli children: 1998-2004. Clin Drug Invest 2006;26(3):161-167
6. Crutchley A, Temlett JA. Methylphenidate (Ritalin) use and abuse. SA Med J 1999;89(10):1076-1079
7. Romano E, Baillargeon RH, Fortier I, Wu H-X, Robaey P, Zoccolillo M, Tremblay RE. Individual change in methylphenidate use in a national sample of children aged 2 to 11 years. Can J Psychiatry March 2005;50(3):144-152 (Pubitemid 40515968)
8. Markowitz JS, Devane CL. Attention-Deficit Hyperactivity Disorder and the rise in methylphenidate use. US Pharm (Supplement) November 2000:3-12.
9. Griggins C. Dosing dilemmas: Are you rich and white or poor and black? Am J Bioethics May/June 2005;5(3):55-57
10. Singh I. Will the "real boy" please behave: Dosing dilemmas for parents of boys with ADHD. Am J Bioethics 2005;5(3):34-47.
11. Brownell MD, Mayer T, Chateau D. The incidence of methylphenidate use by Canadian children: What is the impact of socioeconomic status and urban or rural residence? Can J Psychiatry November 2006;51(13):847-854
12. Monthly Index of Medical Specialities (MIMS). Edited by JR Snyman. Pinegowrie: MIMS. July 2004;44 (7).
13. South African Medicines Formulary (SAMF). Edited by CJ Gibbon. 8th edition. 2008. Cape Town: Health and Medical Publishing Group of the South African Medical Association.
14. Anatomical Therapeutic Chemical (ATC) Classification Index with Defined Daily Doses (DDDs). January 2001. Oslo: WHO Collaborating Centre for Drug Statistics Methodology.
15. Van Jaarsveld A. Methylphenidate prescribing patterns in a retail group in Tshwane. 2006. University of Limpopo (Medunsa Campus): Unpublished MSc (Med) dissertation.
16. Scottish Health Statistics. Statistical Publication Notice: 19 December 2006. Available from: http://www.isdscotland.org/isd/4562.html (Accessed 22/03/2007).
17. Capellà D. Descriptive tools and analysis. In: Drug utilization studies: Methods and uses. Edited by MNG Dukes. Oslo: WHO Regional Publications, European Series, 1993;45:55-78.
18. Truter I. Methylphenidate: Prescribing patterns in a South African primary care patient population. J Clin Pharm Ther February 2005;30(Issue 1):59-63 (Pubitemid 41602092)